<DOC>
	<DOCNO>NCT01358864</DOCNO>
	<brief_summary>The aim trial evaluate efficacy safety BI 201335 give 12 24 week combination PegIFN/RBV give 48 week compare PegIFN/RBV alone chronic GT-1 hepatitis C virus infect patient fail prior PegIFN/RBV treatment .</brief_summary>
	<brief_title>Efficacy Safety BI 201335 ( Faldaprevir ) Combination With Pegylated Interferon-alpha Ribavirin Treatment-Experienced Genotype 1 Hepatitis C Infected Patients ( STARTverso 3 )</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>Inclusion criterion : 1 . Chronic hepatitis C genotype 1 infection , diagnose least 6 month prior screen 2 . Confirmed prior virological failure approve dose PegIFN/RBV 3 . Age 18 70 year , 4 . HCV RNA ( RiboNucleic Acid ) = 1,000 IU/mL screening , Exclusion criterion : 1 . HCV infection mixed genotype ; Hepatitis B Virus ( HBV ) Human Immunodeficiency Virus ( HIV ) coinfection 2 . Evidence acute chronic liver disease due cause chronic HCV infection , 3 . Decompensated liver disease , history decompensated liver disease , 4 . Body weight &lt; 40 &gt; 125 kg , 5 . Clinical evidence significant unstable cardiovascular disease , chronic pulmonary disease , history evidence retinopathy clinically significant ophthalmological disorder 6 . Preexisting psychiatric condition could interfere subject 's participation completion study 7 . Laboratory parameter disorder ( thalassemia major , sickle cell anemia G6PD deficit ) 8 . Hemoglobin &lt; 12 g/dL woman &lt; 13 g/dL men 9 . Patients previously treat least one dose antiviral immunomodulatory drug interferon alfa ribavirin acute chronic HCV infection include restricted protease polymerase inhibitor ,</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>